4.68 USD
↗ 0.01 (0.21%)AT CLOSE (11:59 AM EDT)
AN2 Therapeutics, Inc. Common Stock
ANTXNASDAQ • USD
4.67
↘ 0.01 (0.32%)
POST MARKET (AS OF 05:21 PM EDT)
Post Market
AS OF 05:21 PM EDT
4.67
↘ 0.01 (0.32%)
Market: CLOSED
Shares of AN2 Therapeutics, Inc. Common Stock (ANTX) are trading at $4.67. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, ANTX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$4.58
High?$4.85
Low?$4.58
Prev. Close?$4.67
Volume?66.1K
Avg. Volume?373.7K
VWAP?$4.70
Rel. Volume?0.18x
Bid / Ask
Bid?$2.92 × 100
Ask?$5.53 × 100
Spread?$2.61
Midpoint?$4.23
Valuation & Ratios
Market Cap?168.2M
Shares Out?36.0M
Float?25.9M
Float %?72.2%
P/E Ratio?N/A
P/B Ratio?2.06
EPS?-$0.96
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Themes
Employees
21
Market Cap
168.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-03-25
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025
Phone: (650) 331-9090
MENLO PARK, CA 94025
Phone: (650) 331-9090
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?13.31Safe
Confidence?40%Low
Short InterestElevated
Short % of Float?7.42%Elevated
Short Interest?1.9M
Days to Cover?2.9
Free Float25.9M
Avg Daily Volume670.3K
Settlement Date2026-06-30
Financial Health
Current Ratio?15.73Strong
Quick Ratio?15.73Strong
Cash Ratio?9.62Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.06CHEAP▾
Peers100
S&P73
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-42.3%WEAK▾
S&P3
ROA?-39.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$114.7M
Fundamentals ratios updated end of day